Home Gilead: Another Competitor Bites The Dust
 

Keywords :   


Gilead: Another Competitor Bites The Dust

2014-11-12 04:58:35| Biotech - Topix.net

Despite a very successful 2014 that included an almost quadrupling of earnings, investors remain overly pessimistic on the prospects of Gilead Sciences. The stock is cheap, competitors continue to fail to make inroads into its core hepatitis C franchise and sales there are just getting started and should continue to beat expectations.

Tags: dust bites competitor gilead

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.06Eastern North Pacific Tropical Weather Outlook
02.06Atlantic Tropical Weather Outlook
01.06Mining for Pearlizing Agent 
01.06The Power of Zinc Pyrithione
01.06Downward pH Drift
01.06Adding Fragrances to Hot Pours
01.06The Perils of Progress in the Search for New UV Filters
01.06This Interview Formality Jumpstarts Or Kills Your Chances Altogether
More »